Novo Nordisk mounts legal campaign against companies marketing compounded semaglutide

No­vo Nordisk is ramp­ing up its le­gal cam­paign against med­ical spas, phar­ma­cies and clin­ics mar­ket­ing com­pound­ed ver­sions of its pop­u­lar weight loss and di­a­betes drugs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.